Results 151 to 160 of about 59,390 (261)

Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant, Tise Suzuki, Kiera McGivney, V. S. S. Abhinav Ayyadevara, Sharon Asariah, Jay Deng, Ethan Nyein, Jacqueline Coats, Gary Yu, Yevgeniya J. Ioffe, Christian Hurtz, Juli J. Unternaehrer   +11 more
wiley   +1 more source

Concordance of laboratory assays for claudin 18.2 in gastric cancer tissue samples: independent proficiency testing and a descriptive non-interventional study. [PDF]

Virchows Arch
Röcken C, Höhn AK, Neumann J, Schildhaus HU, Singer S, Clauditz TS, Quaas A, Jöhrens K.   +7 more
europepmc   +1 more source

Proficiency testing for SARS-CoV-2 whole genome sequencing. [PDF]

Pathology, 2022
Lau KA, Horan K, Gonçalves da Silva A, Kaufer A, Theis T, Ballard SA, Rawlinson WD.   +6 more
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Evaluating the Effectiveness of External Molecular Proficiency Testing in the Global Polio Laboratory Network, 2021-2022. [PDF]

Pathogens
Gerloff N, Burns CC.
europepmc   +1 more source

Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue. [PDF]

Virchows Arch, 2023
Vollbrecht C, Hoffmann I, Lehmann A, Merkelbach-Bruse S, Fassunke J, Wagener-Ryczek S, Ball M, Dimitrova L, Hartmann A, Stöhr R, Erber R, Weichert W, Pfarr N, Bohlmann L, Jung A, Dietmaier W, Dietel M, Horst D, Hummel M.   +18 more
europepmc   +1 more source

PANoptosis in the pathogenesis of myelodysplastic syndromes

Molecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang   +4 more
wiley   +1 more source

Novel Approach to Proficiency Testing Reveals Significant Variations in Biomarker Practice Leading to Critical Differences in Lung Cancer Management. [PDF]

JTO Clin Res Rep
Bisson KR, Beharry A, Blais N, Carter MD, Cheema PK, Desmeules P, Garratt JG, Melosky B, Lo B, Snow S, Tessier-Cloutier B, Tio E, Yip S, Won JR, Sheffield BS.   +14 more
europepmc   +1 more source

Results of Proficiency Testing for Trichinella in Poland, 2015-2019. [PDF]

J Clin Med, 2021
Różycki M, Korpysa-Dzirba W, Bełcik A, Bilska-Zając E, Karamon J, Sroka J, Zdybel J, Cencek T.   +7 more
europepmc   +1 more source

proficiency testing provider

Citation: 'proficiency testing provider' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.08102 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual ...
openaire   +1 more source